Clinical Trial Detail

NCT ID NCT02792114
Title T-Cell Therapy for Advanced Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Rimiducid

Mesothelin CAR-T cells

Cyclophosphamide

Age Groups: senior adult

Additional content available in CKB BOOST